Clinical Trial Update: Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction [Phase 3]

View source ↗

Summary

Phase 3 trial update for empagliflozin in acute heart failure regardless of ejection fraction is ongoing; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Acute Heart Failure | Phase 3 | Status: UNKNOWN